| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Jefferson Cancer Institute [K. K., R. B., T. D., M. O., M. G. C., H.I., C. M. C., K. H.] and Department of Surgical Pathology [J. P.], Jefferson Medical College, Philadelphia Pennsylvania 19107-6799; Department of Pathology, University of Padova, Padova, Italy [M. R.]; and Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong [D. H.]
A number of DNA fragments, identified by representational difference analysis, which were homozygously deleted in various cancer cell lines were previously mapped to human chromosomal arms. One of these, BE758-6, which was homozygously deleted in a number of colon carcinoma cell lines, had been mapped to chromosome region 3p. We have further localized the probe to 3p14.2, 
350 kbp telomeric to the 3p14.2 break of the t(3;8) hereditary renal cell carcinoma chromosome translocation, within or near the 3p14.2 FRA3B, the most common human fragile site. We determined the sizes of the homozygous deletions in a number of cancer cell lines after isolation of a yeast artificial chromosome contig and development of STS markers which fall between D3S1234 and D3S1481, which flank the deletions. Homozygous deletions were observed and sized not only in the cell lines originally reported but also in a number of nasopharyngeal carcinoma cell lines and a gastric carcinoma cell line. About 50% of uncultured stomach and colon carcinomas were then shown to lose heterozygosity for alleles in the same region, with a common region of loss between the D3S1234 and D3S1481 markers. Thus, it is likely that the homozygous deletion observed in these cancer cell lines harbors an important tumor suppressor gene for several tumor types.
1 This work was supported by USPHS Grant CA51083, and a gift from R. R. M. Carpenter III and Mary K. Carpenter. National Cancer Institute Cancer Center Grant CA56336 supported the Jefferson Cancer Center shared research facilities, which expedited the study.
2 To whom requests for reprints should be addressed, at Jefferson Cancer Institute, Bluemle Life Sciences Building, Room 1008, 233 South 10th Street, Jefferson Medical College, Philadelphia PA 19107. Phone (215) 955-4656; Fax (215) 923-4498.
Received 12/21/95. Accepted 1/17/96.
This article has been cited by other articles:
|
|
 |
|
  S. G. Durkin, R. L. Ragland, M. F. Arlt, J. G. Mulle, S. T. Warren, and T. W. Glover Replication stress induces tumor-like microdeletions in FHIT/FRA3B PNAS, January 8, 2008; 105(1): 246 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bavi, Z. Jehan, V. Atizado, H. Al-Dossari, F. Al-Dayel, A. Tulbah, S. S. Amr, S. S. Sheikh, A. Ezzat, H. El-Solh, et al. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1708 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wali, R. Srinivasan, M. S. Shabnam, S. Majumdar, K. Joshi, and D. Behera Loss of Fragile Histidine Triad Gene Expression in Advanced Lung Cancer Is Consequent to Allelic Loss at 3p14 Locus and Promoter Methylation Mol. Cancer Res., February 1, 2006; 4(2): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Aqeilan, T. Kuroki, Y. Pekarsky, O. Albagha, F. Trapasso, R. Baffa, K. Huebner, P. Edmonds, and C. M. Croce Loss of WWOX Expression in Gastric Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3053 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Uematsu, A. Yoshimura, A. Gemma, H. Mochimaru, Y. Hosoya, S. Kunugi, K. Matsuda, M. Seike, F. Kurimoto, K. Takenaka, et al. Aberrations in the Fragile Histidine Triad (FHIT) Gene in Idiopathic Pulmonary Fibrosis Cancer Res., December 1, 2001; 61(23): 8527 - 8533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsujiuchi, Y. Sasaki, N. Murata, M. Tsutsumi, Y. Konishi, and D. Nakae FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats Carcinogenesis, December 1, 2001; 22(12): 2017 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-S. Byun, M.-G. Lee, K.-S. Chae, B.-G. Ryu, and S.-G. Chi Frequent Epigenetic Inactivation of RASSF1A by Aberrant Promoter Hypermethylation in Human Gastric Adenocarcinoma Cancer Res., October 1, 2001; 61(19): 7034 - 7038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Auer, C. Jones, R. A. Mullenbach, D. Syndercombe-Court, D. W. Milligan, C. D. Fegan, and F. E. Cotter Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia Blood, January 15, 2001; 97(2): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Kholodnyuk, A. Szeles, Y. Yang, G. Klein, and S. Imreh Inactivation of the Human Fragile Histidine Triad Gene at 3p14.2 in Monochromosomal Human/Mouse Microcell Hybrid-derived Severe Combined Immunodeficient Mouse Tumors Cancer Res., December 1, 2000; 60(24): 7119 - 7125. [Abstract] [Full Text]
|
|
|
|
|
|
R. Baffa, R. Santoro, F. Bullrich, B. Mandes, H. Ishii, and C. M. Croce Definition and Refinement of Chromosome 8p Regions of Loss of Heterozygosity in Gastric Cancer Clin. Cancer Res., April 1, 2000; 6(4): 1372 - 1377. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. W. Paige, K. J. Taylor, A. Stewart, J. G. Sgouros, H. Gabra, G. C. Sellar, J. F. Smyth, D. J. Porteous, and J. E. V. Watson A 700-kb Physical Map of a Region of 16q23.2 Homozygously Deleted in Multiple Cancers and Spanning the Common Fragile Site FRA16D Cancer Res., March 1, 2000; 60(6): 1690 - 1697. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Baffa, L. G. Gomella, A. Vecchione, P. Bassi, K. Mimori, J. Sedor, C. M. Calviello, M. Gardiman, C. Minimo, S. E. Strup, et al. Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary Bladder Am. J. Pathol., February 1, 2000; 156(2): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. P. Hao, J. E. Willis, T. G. Pretlow, J. S. Rao, G. T. MacLennan, I. C. Talbot, and T. P. Pretlow Loss of Fragile Histidine Triad Expression in Colorectal Carcinomas and Premalignant Lesions Cancer Res., January 1, 2000; 60(1): 18 - 21. [Abstract] [Full Text]
|
|
|
|
|
|
L. Gramantieri, P. Chieco, M. Di Tomaso, L. Masi, F. Piscaglia, S. Brillanti, S. Gaiani, M. Valgimigli, A. Mazziotti, and L. Bolondi Aberrant Fragile Histidine Triad Gene Transcripts in Primary Hepatocellular Carcinoma and Liver Cirrhosis Clin. Cancer Res., November 1, 1999; 5(11): 3468 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hallas, M. Albitar, J. Letofsky, M. J. Keating, K. Huebner, and C. M. Croce Loss of FHIT Expression in Acute Lymphoblastic Leukemia Clin. Cancer Res., September 1, 1999; 5(9): 2409 - 2414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Chaudhuri, I. A. Khan, V. Prasad, A. K. Robinson, R. F. Luduena, and L. D. Barnes The Tumor Suppressor Protein Fhit. A NOVEL INTERACTION WITH TUBULIN J. Biol. Chem., August 20, 1999; 274(34): 24378 - 24382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Yustein, J. C. Harper, G. R. Petroni, O. W. Cummings, C. A. Moskaluk, and S. M. Powell Allelotype of Gastric Adenocarcinoma Cancer Res., April 1, 1999; 59(7): 1437 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inoue, H. Ishii, H. Alder, E. Snyder, T. Druck, K. Huebner, and C. M. Croce Sequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion PNAS, December 23, 1997; 94(26): 14584 - 14589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Siprashvili, G. Sozzi, L. D. Barnes, P. McCue, A. K. Robinson, V. Eryomin, L. Sard, E. Tagliabue, A. Greco, L. Fusetti, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity PNAS, December 9, 1997; 94(25): 13771 - 13776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sugimoto, K. Yamada, K. Miyagawa, H. Hirai, and K. Oshimi Decreased or Altered Expression of the FHIT Gene in Human Leukemias Stem Cells, May 1, 1997; 15(3): 223 - 228. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
